Adjuvant breast cancer vaccine improves overall survival of patients with depressed immunity

被引：0
|
作者：
Head, Jonathan F. [1 ]
Elliott, Robert L. [1 ]
机构：
[1] OncBioMune, Baton Rouge, LA USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-5370
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5370
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Host Immunity and Disease Free Survival are Improved in Breast Cancer Patients Receiving an Autologous Vaccine
    Head, Jonathan F.
    Elliott, Robert L.
    JOURNAL OF IMMUNOTHERAPY, 2010, 33 (08) : 916 - 917
  • [22] Ribociclib in combination with endocrine therapy improves overall survival of pre-/perimenopausal breast cancer patients
    Krug, David
    Fabian, Alexander
    Dunst, Juergen
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (03) : 286 - 288
  • [23] Correlation of breast arterial calcification with overall survival in patients with breast cancer
    Dusi, Vidya Sagar
    Attili, Suresh V. S.
    Vutukuru, Anuradha
    Peri, Soumya V.
    Sharma, Rakesh
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [24] Adjuvant Chemotherapy Improves Overall Survival of Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy Regardless of Pathologic Nodal Status
    Kulaylat, Audrey S.
    Hollenbeak, Christopher S.
    Stewart, David B., Sr.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (05) : 1281 - 1288
  • [25] Adjuvant trastuzumab plus chemotherapy improves disease-free survival in early breast cancer patients
    不详
    ONCOLOGY-NEW YORK, 2005, 19 (06): : 800 - 800
  • [26] Adjuvant Chemotherapy Improves Overall Survival of Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy Regardless of Pathologic Nodal Status
    Audrey S. Kulaylat
    Christopher S. Hollenbeak
    David B. Stewart
    Annals of Surgical Oncology, 2017, 24 : 1281 - 1288
  • [27] Overall Survival With Adjuvant mFOLFIRINOX for Pancreatic Cancer
    Reni, Michele
    Macchini, Marina
    Porcu, Luca
    JAMA ONCOLOGY, 2023, 9 (03) : 435 - 436
  • [28] Adjuvant oral clodronate improves the overall survival of primary breast cancer patients with micrometastases to the bone marrow-a long-term follow-up
    Diel, I. J.
    Jaschke, A.
    Solomayer, E. F.
    Gollan, C.
    Bastert, G.
    Sohn, C.
    Schuetz, F.
    ANNALS OF ONCOLOGY, 2008, 19 (12) : 2007 - 2011
  • [29] Weekly adjuvant paclitaxel improves survival after standard chemotherapy in breast cancer
    Nature Clinical Practice Oncology, 2008, 5 (9): : 498 - 498
  • [30] Overall survival in patients with breast cancer according molecular subtypes
    Nikolov, S.
    Minkov, G.
    Enchev, E.
    Gulubova, M.
    Vlaykova, T.
    Yovtchev, Y.
    BREAST, 2017, 32 : S101 - S102
12345